Literature DB >> 24257612

The canarypox virus vector ALVAC induces distinct cytokine responses compared to the vaccinia virus-based vectors MVA and NYVAC in rhesus monkeys.

Jeffrey E Teigler1, Sanjay Phogat, Genoveffa Franchini, Vanessa M Hirsch, Nelson L Michael, Dan H Barouch.   

Abstract

Despite the growing use of poxvirus vectors as vaccine candidates for multiple pathogens and cancers, their innate stimulatory properties remain poorly characterized. Here we show that the canarypox virus-based vector ALVAC induced distinct systemic proinflammatory and antiviral cytokine and chemokine levels following the vaccination of rhesus monkeys compared to the vaccinia virus-based vectors MVA and NYVAC. These data suggest that there are substantial biological differences among leading poxvirus vaccine vectors that may influence resultant adaptive immune responses following vaccination.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24257612      PMCID: PMC3911591          DOI: 10.1128/JVI.02386-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells.

Authors:  Susana Guerra; Luis A López-Fernández; Alberto Pascual-Montano; José Luis Nájera; Angel Zaballos; Mariano Esteban
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.

Authors:  Audrey Ferrier-Rembert; Robert Drillien; Jean-Nicolas Tournier; Daniel Garin; Jean-Marc Crance
Journal:  Vaccine       Date:  2008-02-12       Impact factor: 3.641

3.  Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

Authors:  J Benson; C Chougnet; M Robert-Guroff; D Montefiori; P Markham; G Shearer; R C Gallo; M Cranage; E Paoletti; K Limbach; D Venzon; J Tartaglia; G Franchini
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 4.  Evasion of apoptosis by DNA viruses.

Authors:  S Cuff; J Ruby
Journal:  Immunol Cell Biol       Date:  1996-12       Impact factor: 5.126

5.  Comparative analysis of tropism between canarypox (ALVAC) and vaccinia viruses reveals a more restricted and preferential tropism of ALVAC for human cells of the monocytic lineage.

Authors:  Qigui Yu; Brad Jones; Ningjie Hu; Hong Chang; Sidrah Ahmad; Jun Liu; Mark Parrington; Mario Ostrowski
Journal:  Vaccine       Date:  2006-06-30       Impact factor: 3.641

Review 6.  The interferon system and vaccinia virus evasion mechanisms.

Authors:  Beatriz Perdiguero; Mariano Esteban
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

7.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Authors:  Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Journal:  N Engl J Med       Date:  2009-10-20       Impact factor: 91.245

8.  Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.

Authors:  Susana Guerra; José Luis Nájera; José Manuel González; Luis A López-Fernández; Nuria Climent; José M Gatell; Teresa Gallart; Mariano Esteban
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

9.  Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates.

Authors:  Petra Mooij; Sunita S Balla-Jhagjhoorsingh; Gerrit Koopman; Niels Beenhakker; Patricia van Haaften; Ilona Baak; Ivonne G Nieuwenhuis; Ivanela Kondova; Ralf Wagner; Hans Wolf; Carmen E Gómez; José L Nájera; Victoria Jiménez; Mariano Esteban; Jonathan L Heeney
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

Review 10.  Poxvirus tropism.

Authors:  Grant McFadden
Journal:  Nat Rev Microbiol       Date:  2005-03       Impact factor: 60.633

View more
  40 in total

1.  The 135 Gene of Goatpox Virus Encodes an Inhibitor of NF-κB and Apoptosis and May Serve as an Improved Insertion Site To Generate Vectored Live Vaccine.

Authors:  Minmin Zhang; Yirui Sun; Weiye Chen; Zhigao Bu
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

Review 2.  New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design.

Authors:  Thomas Musich; Marjorie Robert-Guroff
Journal:  Expert Rev Vaccines       Date:  2016-03-16       Impact factor: 5.217

3.  Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates.

Authors:  Juan García-Arriaza; Beatriz Perdiguero; Jonathan Heeney; Michael Seaman; David C Montefiori; Celia Labranche; Nicole L Yates; Xiaoying Shen; Georgia D Tomaras; Guido Ferrari; Kathryn E Foulds; Adrian McDermott; Shing-Fen Kao; Mario Roederer; Natalie Hawkins; Steve Self; Jiansheng Yao; Patrick Farrell; Sanjay Phogat; Jim Tartaglia; Susan W Barnett; Brian Burke; Anthony Cristillo; Deborah Weiss; Carter Lee; Karen Kibler; Bert Jacobs; Benedikt Asbach; Ralf Wagner; Song Ding; Giuseppe Pantaleo; Mariano Esteban
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

4.  Distinct Roles of Vaccinia Virus NF-κB Inhibitor Proteins A52, B15, and K7 in the Immune Response.

Authors:  Mauro Di Pilato; Ernesto Mejías-Pérez; Carlos Oscar S Sorzano; Mariano Esteban
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

Review 5.  HIV-1 vaccines: challenges and new perspectives.

Authors:  Jean-Louis Excler; Merlin L Robb; Jerome H Kim
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

6.  Priming and Activation of Inflammasome by Canarypox Virus Vector ALVAC via the cGAS/IFI16-STING-Type I IFN Pathway and AIM2 Sensor.

Authors:  Fengliang Liu; Qingli Niu; Xiuzhen Fan; Connie Liu; Jie Zhang; Zhi Wei; Wei Hou; Thirumala-Devi Kanneganti; Merlin L Robb; Jerome H Kim; Nelson L Michael; Jiaren Sun; Lynn Soong; Haitao Hu
Journal:  J Immunol       Date:  2017-09-25       Impact factor: 5.422

Review 7.  Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines.

Authors:  Jean-Louis Excler; Julie Ake; Merlin L Robb; Jerome H Kim; Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2014-06-11

8.  HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition.

Authors:  Monica Vaccari; Slim Fourati; Shari N Gordon; Dallas R Brown; Massimilano Bissa; Luca Schifanella; Isabela Silva de Castro; Melvin N Doster; Veronica Galli; Maria Omsland; Dai Fujikawa; Giacomo Gorini; Namal P M Liyanage; Hung V Trinh; Katherine M McKinnon; Kathryn E Foulds; Brandon F Keele; Mario Roederer; Richard A Koup; Xiaoying Shen; Georgia D Tomaras; Marcus P Wong; Karissa J Munoz; Johannes S Gach; Donald N Forthal; David C Montefiori; David J Venzon; Barbara K Felber; Margherita Rosati; George N Pavlakis; Mangala Rao; Rafick-Pierre Sekaly; Genoveffa Franchini
Journal:  Nat Med       Date:  2018-05-21       Impact factor: 53.440

9.  Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells.

Authors:  Nicholas M Provine; Rafael A Larocca; Malika Aid; Pablo Penaloza-MacMaster; Alexander Badamchi-Zadeh; Erica N Borducchi; Kathleen B Yates; Peter Abbink; Marinela Kirilova; David Ng'ang'a; Jonathan Bramson; W Nicholas Haining; Dan H Barouch
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

10.  Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir size.

Authors:  Jeffrey E Teigler; Louise Leyre; Nicolas Chomont; Bonnie Slike; Ningbo Jian; Michael A Eller; Nittaya Phanuphak; Eugène Kroon; Suteeraporn Pinyakorn; Leigh Anne Eller; Merlin L Robb; Jintanat Ananworanich; Nelson L Michael; Hendrik Streeck; Shelly J Krebs
Journal:  JCI Insight       Date:  2018-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.